Clinical Trial Update: Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating anosmia rehabilitation in patients with olfactory disorder after COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olfactory Disorder

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Olfactory Disorder | Phase 4 | Status: WITHDRAWN